Wells Fargo’s Scinai Immunotherapeutics SCNI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2
| Closed | -$12 | – | 7167 |
|
|
2023
Q4 | $12 | Hold |
2
| – | – | ﹤0.01% | 6904 |
|
|
2023
Q3 | $17 | Hold |
2
| – | – | ﹤0.01% | 6890 |
|
|
2023
Q2 | $28 | Hold |
2
| – | – | ﹤0.01% | 6907 |
|
|
2023
Q1 | $43 | Hold |
2
| – | – | ﹤0.01% | 6826 |
|
|
2022
Q4 | $59 | Hold |
2
| – | – | ﹤0.01% | 6632 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 6923 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 7065 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7149 |
|
|
2021
Q4 | $0 | Sell |
2
-1
| -33% | – | ﹤0.01% | 7134 |
|
|
2021
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 6445 |
|
|
2021
Q2 | $1K | Sell |
3
-6
| -67% | -$2K | ﹤0.01% | 6380 |
|
|
2021
Q1 | $3K | Sell |
9
-8
| -47% | -$2.67K | ﹤0.01% | 6222 |
|
|
2020
Q4 | $5K | Sell |
17
-21
| -55% | -$6.18K | ﹤0.01% | 5851 |
|
|
2020
Q3 | $147K | Buy |
38
+26
| +217% | +$101K | ﹤0.01% | 4925 |
|
|
2020
Q2 | $27K | Buy |
12
+3
| +33% | +$6.75K | ﹤0.01% | 5340 |
|
|
2020
Q1 | $7K | Hold |
9
| – | – | ﹤0.01% | 5517 |
|
|
2019
Q4 | $8K | Hold |
9
| – | – | ﹤0.01% | 5609 |
|
|
2019
Q3 | $5K | Hold |
9
| – | – | ﹤0.01% | 5645 |
|
|
2019
Q2 | $5K | Hold |
9
| – | – | ﹤0.01% | 5619 |
|
|
2019
Q1 | $5K | Hold |
9
| – | – | ﹤0.01% | 5613 |
|
|
2018
Q4 | $4K | Hold |
9
| – | – | ﹤0.01% | 5683 |
|
|
2018
Q3 | $5K | Hold |
9
| – | – | ﹤0.01% | 5701 |
|
|
2018
Q2 | $6K | Hold |
9
| – | – | ﹤0.01% | 5690 |
|
|
2018
Q1 | $5K | Sell |
9
-1
| -10% | -$556 | ﹤0.01% | 5653 |
|
|
2017
Q4 | $5K | Hold |
10
| – | – | ﹤0.01% | 5647 |
|
|
2017
Q3 | $7K | Buy |
10
+3
| +43% | +$2.1K | ﹤0.01% | 5580 |
|
|
2017
Q2 | $6K | Buy |
+7
| New | +$6K | ﹤0.01% | 5522 |
|